Prediabetes is a condition characterized by blood sugar levels that are higher than normal but not yet high enough to be classified as diabetes. According to a study published in *Diabetes Care*, two key indicators of prediabetes are Impaired Glucose Tolerance (IGT) and Impaired Fasting Glucose (IFG). As of 2021, approximately 9.

1% of adults were found to have IGT, while 5.8% had IFG. Alarmingly, projections indicate that by 2045, these numbers could escalate to 638 million individuals with IGT and 414 million with IFG, with the most significant growth expected in low-income countries.

This rise highlights the urgent need for increased awareness, prevention strategies, and health interventions to combat the growing prevalence of prediabetes and its potential progression to diabetes..